XML 38 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
OPERATING ACTIVITIES    
Net income $ 70.3 $ 33.0
Reconciliation to net cash provided by operating activities:    
Depreciation and amortization 27.0 24.4
Amortization of debt discount and financing costs 2.0 0.0
Stock-based compensation expense 5.0 2.8
Gain on termination and curtailment of pension and other postretirement plans (2.6) 0.0
Currency and other losses in Venezuela 4.2 73.2
Deferred income taxes 2.2 (7.3)
Excess tax benefits from stock-based compensation 0.0 (2.8)
Loss on disposal of property and equipment 0.5 3.9
Changes in assets and liabilities, excluding effect of currency translation:    
Trade accounts receivable (37.0) (51.7)
Inventories (10.9) (13.2)
Accounts payable 9.4 17.1
Pension assets and liabilities, net 3.4 (0.6)
Other assets and liabilities, net (0.5) 23.1
Net cash provided by operating activities 73.0 101.9
INVESTING ACTIVITIES    
Capital expenditures (33.3) (26.2)
Receipt of payment on loan from related party 0.0 40.0
Other investing activities 0.5 0.4
Net cash (used in) provided by investing activities (32.8) 14.2
FINANCING ACTIVITIES    
Borrowings under credit arrangements 294.3 27.6
Repayments under credit arrangements (30.7) (41.0)
Borrowings under related party loans 0.0 2.1
Repayments under related party loans 0.0 (5.9)
Proceeds from issuance of bonds 525.0 0.0
Cash paid for debt financing costs (18.2) 0.0
Share repurchase under GCP 2016 Stock Incentive Plan (1.8) 0.0
Proceeds from exercise of stock options 3.8 0.0
Excess tax benefits from stock-based compensation 0.0 2.8
Noncontrolling interest dividend (0.7) 0.0
Transfers to parent, net (764.6) (69.6)
Net cash provided by (used in) financing activities 7.1 (84.0)
Effect of currency exchange rate changes on cash and cash equivalents 2.6 (53.1)
Increase (decrease) in cash and cash equivalents 49.9 (21.0)
Cash and cash equivalents, beginning of period 98.6 120.9
Cash and cash equivalents, end of period $ 148.5 $ 99.9